HM Arnhem, Netherlands

Wiro M P B Menge


 

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Wiro M P B Menge: Innovator in Pharmaceutical Chemistry

Introduction

Wiro M P B Menge is a notable inventor based in HM Arnhem, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 5 patents to his name, Menge's work has garnered attention in the scientific community.

Latest Patents

One of his latest patents involves pyrazolone derivatives as PDE4 inhibitors. The compound 1-(2-{4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione is recognized as a novel effective inhibitor of type 4 phosphodiesterase. This compound shows promise in the treatment of psoriasis and atopic dermatitis, highlighting Menge's innovative approach to addressing complex medical conditions.

Career Highlights

Throughout his career, Wiro M P B Menge has worked with prominent companies in the pharmaceutical industry, including Nycomed GmbH and Takeda GmbH. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development projects.

Collaborations

Menge has collaborated with several professionals in his field, including Geert Jan Sterk and Beate Schmidt. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective projects.

Conclusion

Wiro M P B Menge stands out as a significant figure in pharmaceutical innovation. His contributions, particularly in the development of PDE4 inhibitors, demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…